文献速递脑血管病

血清半乳糖凝集素-3与急性缺血性卒中不良结局的关系

Serum Galectin-3 and Poor Outcomes Among Patients With Acute Ischemic Stroke.
PubMed 文献 · Stroke · 2017-12-11

该研究在3082例急性缺血性卒中患者中检测血清半乳糖凝集素-3水平,发现最高四分位组相比最低四分位组,3个月死亡或主要残疾复合结局的校正OR为1.55(95%CI 1.15-2.09),主要残疾OR为1.43(1.05-1.93),且加入半乳糖凝集素-3可改善预测(NRI 18.9%,P<0.001)。

要点

  • 高血清半乳糖凝集素-3与急性缺血性卒中后3个月死亡或主要残疾风险独立相关。
  • 半乳糖凝集素-3可提升传统危险因素对不良结局的预测能力(NRI 18.9%)。
  • 该指标可能作为缺血性卒中预后评估的潜在生物标志物。

核心结论

  • 较高的血清半乳糖凝集素-3水平与卒中后死亡或主要残疾风险增加独立相关,提示其可能具有预后价值。

研究设计与样本

  • 研究纳入3082例急性缺血性卒中患者,检测血清半乳糖凝集素-3水平,主要结局为卒中后3个月死亡或主要残疾(改良Rankin量表评分≥3)的复合结局。

主要发现

  • 与最低四分位组相比,最高四分位组半乳糖凝集素-3的多因素校正OR(95%CI)为:复合结局1.55(1.15-2.09),死亡2.10(0.89-4.95),主要残疾1.43(1.05-1.93)。
  • 将半乳糖凝集素-3加入传统危险因素后,显著改善了对死亡或主要残疾复合结局的预测(净重分类指数18.9%,P<0.001;综合判别改善指数0.4%,P=0.001)。

临床怎么用

  • 在急性缺血性卒中患者中,可考虑检测血清半乳糖凝集素-3以辅助评估3个月死亡或主要残疾的风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Elevated galectin-3 has been associated with atherosclerosis and poor outcomes in patients with heart failure. However, it remains unclear whether galectin-3 has any effect on the poor outcomes of ischemic stroke. The aim of the present study was to examine the association between galectin-3 with poor outcomes among patients with acute ischemic stroke. METHODS: Serum galectin-3 was measured in 3082 patients with acute ischemic stroke. The primary outcome was a combination of death or major disability (modified Rankin Scale score, ≥3) at 3 months after stroke. RESULTS: Compared with the lowest quartile of galectin-3, multivariate adjusted odds ratios (95% confidence intervals) for the highest quartile of galectin-3 were 1.55 (1.15-2.09) for composite outcome, 2.10 (0.89-4.95) for death, and 1.43 (1.05-1.93) for major disability. The addition of galectin-3 to the conventional risk factors significantly improved prediction of the combined outcome of death or major disability in patients with ischemic stroke (net reclassification index, 18.9%; P<0.001; integrated discrimination improvement, 0.4%; P=0.001). CONCLUSIONS: Higher levels of serum galectin-3 were independently associated with increased risk of death or major disability after stroke onset, suggesting that galectin-3 may have prognostic value in poor outcomes of ischemic stroke.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Wang A, Zhong C, Zhu Z, et al. Serum Galectin-3 and Poor Outcomes Among Patients With Acute Ischemic Stroke. Stroke. 2017. PMID: 29229724. doi:10.1161/STROKEAHA.117.019084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。